Group 1 - The latest stock price of Aihuilong is 15.63 yuan, up 0.77% from the previous trading day, with an intraday high of 15.85 yuan and a low of 15.53 yuan, and a trading volume of 1.28 billion yuan [1] - Aihuilong operates in the medical device industry, focusing on the research, production, and sales of in vitro diagnostic products, which include immunodiagnostics, biochemical diagnostics, and molecular diagnostics, primarily used in hospital laboratories and health examination centers [1] - On August 18, the company announced that its controlling shareholder and chairman, Hu Kunhui, plans to reduce his stake by no more than 3%, while the deputy general manager and core technical personnel, Xiao Yujin, plans to reduce his stake by no more than 0.11% [1] Group 2 - The company has provided guarantees of up to 115 million yuan for four wholly-owned subsidiaries, with the current balance of guarantees by the company and its controlling subsidiaries amounting to approximately 315 million yuan [1] - In terms of capital flow, the main funds saw a net outflow of 7.99 million yuan on that day, with a cumulative net outflow of 54.24 million yuan over the past five days [1]
亚辉龙股价微涨0.77% 实控人拟减持3%股份